Published in Elder Law Weekly, December 1st, 2004
"There is growing experimental evidence for the implication of glutamate-mediated mechanisms both in the pathophysiology of Parkinson disease and in the development of dyskinesias with long-term administration of L-3,4-dihydroxyphenylalanine (L-DOPA)," scientists in France explained. "However, the impact of this treatment on glutamate transmission in the basal ganglia has been poorly investigated."
In a recent study, S. Robelet and coauthors at UMR 6186 in Marseille "examined the effects of 6-hydroxydopamine-induced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.